Rice Hall James & Associates LLC Takes Position in Maximus, Inc. $MMS

Key Points

• Rice Hall James & Associates acquired 278,910 Maximus shares worth approximately $15 million, while other institutional investors also increased their holdings. Institutions now own 97.21% of the company.
• Maximus exceeded quarterly EPS expectations slightly at $2.22, but revenue of $1.28 billion fell short of forecasts and declined 5.1% year over year. Shares opened at $54.43, near their 52-week low of $52.73.
• The company declared a quarterly dividend of $0.33 per share, representing a 2.4% annualized yield. Analyst sentiment remains weak, with recent downgrades leading to a consensus “Reduce” rating.

Rice Hall James & Associates LLC purchased a new position in shares of Maximus, Inc. (NYSE:MMS - Free Report) during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 278,910 shares of the health services provider's stock, valued at approximately $14,994,000. Rice Hall James & Associates LLC owned 0.53% of Maximus at the end of the most recent quarter.

Several other hedge funds have also made changes to their positions in the stock. Reinhart Partners LLC. grew its stake in Maximus by 131.8% during the 2nd quarter. Reinhart Partners LLC. now owns 1,982,415 shares of the health services provider's stock worth $106,575,000 after buying an additional 1,127,346 shares during the last quarter. Norges Bank bought a new stake in Maximus in the fourth quarter valued at $60,393,000. River Road Asset Management LLC lifted its stake in Maximus by 236.1% in the fourth quarter. River Road Asset Management LLC now owns 823,262 shares of the health services provider's stock valued at $71,064,000 after buying an additional 578,326 shares during the last quarter. Bank of New York Mellon Corp acquired a new position in shares of Maximus during the second quarter valued at $26,239,000. Finally, Goldman Sachs Group Inc. boosted its holdings in shares of Maximus by 218.4% during the fourth quarter. Goldman Sachs Group Inc. now owns 583,627 shares of the health services provider's stock valued at $50,379,000 after acquiring an additional 400,315 shares during the period. Institutional investors own 97.21% of the company's stock.

Maximus Stock Performance

Shares of MMS opened at $54.43 on Tuesday. The firm has a 50-day moving average price of $57.94 and a 200 day moving average price of $65.43. The firm has a market capitalization of $2.85 billion, a PE ratio of 8.04 and a beta of 0.59. The company has a quick ratio of 2.42, a current ratio of 2.42 and a debt-to-equity ratio of 0.90. Maximus, Inc. has a 52-week low of $52.73 and a 52-week high of $100.00.

Maximus (NYSE:MMS - Get Free Report) last released its earnings results on Thursday, August 6th. The health services provider reported $2.22 EPS for the quarter, beating the consensus estimate of $2.21 by $0.01. The firm had revenue of $1.28 billion for the quarter, compared to analysts' expectations of $1.33 billion. Maximus had a net margin of 7.07% and a return on equity of 24.91%. Maximus's quarterly revenue was down 5.1% on a year-over-year basis. During the same quarter last year, the company earned $2.16 EPS. Maximus has set its FY 2026 guidance at 7.900-8.200 EPS. On average, sell-side analysts anticipate that Maximus, Inc. will post 8.01 earnings per share for the current fiscal year.

Maximus Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, August 31st. Investors of record on Friday, August 14th will be paid a dividend of $0.33 per share. This represents a $1.32 dividend on an annualized basis and a dividend yield of 2.4%. The ex-dividend date is Friday, August 14th. Maximus's dividend payout ratio (DPR) is currently 19.50%.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on the company. Wall Street Zen cut Maximus from a "buy" rating to a "hold" rating in a report on Saturday, August 8th. Zacks Research lowered Maximus from a "hold" rating to a "strong sell" rating in a report on Tuesday, August 11th. Finally, Weiss Ratings cut Maximus from a "hold (c)" rating to a "hold (c-)" rating in a research report on Wednesday, May 20th. One analyst has rated the stock with a Hold rating and one has given a Sell rating to the company. According to MarketBeat, Maximus has a consensus rating of "Reduce".

Maximus Company Profile

Maximus, Inc NYSE: MMS is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children's Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source